Genetic heterogeneity in tumours is the bonafide hallmark applicable to all cancer types (Burrell et al, 2013) . Furthermore, deregulated ribosome biogenesis and elevated protein biosynthesis have been consistently associated with multiple cancer types (Ruggero, 2012; Ruggero & Pandolfi, 2003) . We observed that under cultivation conditions almost all cancer cell types actively shed significant amount of particulates as compared to non-malignant cell lines requiring frequent changing of cultivation media. We therefore asked if cancer cell shed particulates might still retain biological activity associated with protein biosynthesis. Here, we communicate our observations of DNAdependent protein biosynthetic activity exhibited by the cell-free particulates shed by the cancer cell lines. Using pulsed isotope labelling approach we confirmed the cell-free protein translation activity exhibited by particulates shed by various cancer cell lines. Interestingly, the bioactivity was largely dependent on temperature, pH and on 3'-DNA elements. Our results demonstrate that cancer shed particulates are biologically active and may potentially drive expression of tissue non-specific promoters in distant organs.
Introduction
For over decades cancer has eluded researchers alike in the search for cancer-specific factors. The search for proteins whose expression is limited only to cancer tissue has largely remained elusive (Scudellari, 2011) . To the best of our knowledge the only bonafide hallmark that is common to all cancer types, is the plethora of heterogeneous somatic variations occurring in malignant tumours.
Although, recent immunotherapeutic approaches seem to indirectly take advantage of this somatic heterogeneity property of cancer (Tran et al, 2017) , it remains to be seen if the potential of immune system can be turned towards other hallmarks of cancers.
Recently, we observed an intriguing phenomenon that we speculate to be a common property of all malignant cells. We observed that cancer cell cultures and tumours in vivo (Supplementary The bioactive nature of particulates to drive tissue independent promoters also suggests that the malignant tumours may possibly be adopting alternative mechanisms for cancer metastasis to distant tissues.
Results

DNA-dependent protein translation by the cancer cell culture supernatants
To assess the bioactivity of cancer cell shed particulates in driving promoter dependent translation, a reporter construct comprising of 3.7 kb human lung surfactant protein C (SPC) promoter (Glasser et al, 1990 ) upstream of nanoluciferase (~25 kDa) open reading frame (ORFs) with SV40 poly-A termination signal sequence was generated. Promoterless construct served as controls. Purified DNA upon incubation with particulates derived from culture supernatants of human lung cancer cell line H1944 at 33 degrees Celsius, resulted in expression of nanoluciferase protein as assessed by immunoblot analysis ( Figure. 1a) and luciferase enzyme activity assays ( Figure. 1b) . Expression of reporter proteins depended on the presence of promoter DNA and was abolished at elevated pH (alkaline) and temperatures (90 degrees Celsius). Synthesis of reporter protein without the addition of any exogenous factors suggests, cancer cells-shed particulates in culture supernatants is most likely composed of all minimal enzymatic components required for de-novo synthesis of proteins.
Concordantly, a concentration dependent effect was observed when cell culture supernatants diluted in RPMI media was co-incubated with the reporter DNAs driven by either sis-inducible element (SIE) or SPC promoter (Figure. 2).
Tissue non-specific promoter activity by the cancer cell culture supernatants Lung promoter driven expression of the nanoluciferase reporter was also exhibited by the culture supernatants of the breast, skin and pancreatic cancer cell lines as assessed by luciferase enzyme activity measurements ( Figure. 3) and immunoblot analyses ( Figure. 
Confirmation of de novo protein synthesis
To determine if reporter expression was due to de novo synthesis of nanoluciferase encoded by the plasmid DNA, NCI-H1944 lung cancer cell culture supernatant was pulsed with 13C6 15N4 SILAC arginine isotope and coincubated with pNL/hSPC-nLuc reporter DNA at 33 ̊ C for 2 hours followed by mass spectrometry analysis of tryptic peptides. We identified several SILAC labelled peptides covering the nanoluciferase protein ( Figure. (b) Quantification of reporter protein by functional assay was achieved by measuring the luciferase activity present in cancer cell culture supernatants in the absence or presence of DNA encoding reporter. DNA encoding reporter (nanoluciferase) is either driven by a 3.7 kb human lung surfactant protein C (hSPC) promoter or contains no promoter (hSPC deleted in the same construct using restriction enzymes). The SPC promoter DNA was PCR amplified from human genomic DNA and the 3.7 kb region is orthologous to the published mouse SPC promoter DNA (Glasser et al, 1990 Fixed amount of 2 µg reporter DNA was used in all reactions for both the reporters namely, pNL/hSPC-nLuc and pNL/SIE-nLuc luciferase. SIE stands for STAT3 inducible elements and pNL/SIE (Promega, #CS189701) is an unaltered commercially available reporter DNA for measuring STAT3 dependent transcription. Although SIE promoter is only 130 bp long compared to hSPC promoter which is 3.7 kb long, cancer cell culture supernatants were still able to drive protein translation in a concentration dependent manner.
Similarly, dose response phenomenon was also observed when the amount of reporter DNA was varied keeping the concentration of culture supernatants constant (Data not shown). 
Fig. 6 Mass spectrometry identification of pulse-SILAC labelled luciferase reporter protein
Cell free DNA driven protein translation was confirmed by mass spectrometry identification of pulse SILAC stable isotope labelled arginine amino acids in luciferase reporter. NCI-H1944 lung cancer cell culture supernatant was mixed with 13C6 15N4 arginine isotope and pNL/hSPC-nLuc DNA and incubated at 33 ̊ C for 2 hours. After two hours the reaction mixture was subjected to trypsin digestion overnight and samples were prepared for mass spectrometry. Detection of SILAC labelled luciferase protein confirms cell free translation. 
Western Blot analysis
Reaction mixtures were directly mixed with 3X Laemmli buffer, were run out on 4-15% Mini-PROTEAN TGX Gels (Bio-Rad 456-1083) and subsequently transferred onto a nitrocellulose membrane. The blots were blocked in 1× NET-Gelatin buffer (1.5 M NaCl, 0.05 M EDTA, 0.5 M Tris pH 7.5, 0.5% Triton X-100 and 0.25 g ml−1 gelatin) and incubated with primary antibodies overnight at 4 °C. For quantitative assessments of protein expression samples were analyzed by standard immunoblotting techniques using following antibodies: Rabbit nanoluciferase antibody (Promega) and GAPDH (D16H11) XP Rabbit mAb-HRP conjugate (#8884 , Cell Signaling)
Preparation of cell culture supernatant-derived particulates
Cell lines were cultivated in complete RPMI medium until a confluency of 70-80 % was reached in 15 cm culture dishes. Subsequently, cultivation medium was changed to 5 mL of serum free RPMI medium and cell lines were cultured until 80-90 % confluency was attained. Next day, 5 mL of culture supernatant was collected and centrifuged at 290g for 60 minutes at room temperature. 1 ml of un-pelleted supernatant was transferred to a new collection tube and used for cell-free translation experiments.
Nanoluciferase activity assays
Nanoluciferase reporter enzyme activity was assessed using Nano-Glo luciferase assay system (#N1150, Promega) according to manufacturers guidelines. In brief, 50 µl of reaction sample was mixed with equal volumes of Nano-Glo luciferase assay substrate dissolved in substrate buffer. After a short incubation of 3 mins, luminescence was measured with the luminometer (EG&G Berthold Technologies, LB96v).
Mass spectrometry analysis
Cancer cell culture derived particulates were co-incubated with or without SPC-nLuc-SV40pA plasmid vector in the presence or absence of 10 µM isotopic Arginine ( 13 C 6 15 N 4 ) for 2 hours. Samples were subjected to reduction in 1 mM DDT (Sigma) for 45 min at 56 °C, S-carbamidomethylation in 5.5 mM iodoacetamide (Sigma) for 30 min in the dark and were digested using Trypsin (sequencing grade, Promega) at 37 degrees Celsius for overnight. The resulting peptide mixtures were acidified with 3% (v/v final) trifluoroacetic acid (TFA) followed by desalting and concentration in microcolumns (StageTips) consisting of a disc of C-18 reverse-phase material (Empore Disc, 3 m) as described (Rappsilber et al, 2003) . Samples were analysed using Q-Exactive Hybrid QuadrupoleOrbitrap Mass Spectrometer (Thermo Fisher Scientific, USA) and .raw files were analysed using PEAKS Studio 8 (Bioinformatics Solutions Inc. Canada)
